Breaking News

You are here » Indian-Commodity  :  Corporate  :  RIL's telecom arm enters into exclusive partnership with Screenz

18-May2018

RIL's telecom arm enters into exclusive partnership with Screenz

Reliance Industries' (RIL) telecom arm - Reliance Jio Infocomm (Jio) has entered into exclusive partnership for the Indian market with Screenz, the most powerful platform for entertainment-based interactivity used by world's top broadcasters and format owners. With this exclusive partnership, Jio Screenz will become the largest platform and one of the only integrated providers of entertainment-based gamification in India.

The partnership will add to Jio's existing platform for gamification, which has proven itself time and again, as seen during the on-going Jio Cricket Play Along, where it has enrolled over 65 million unique users already, who are consistently playing the game as well as the Jio Kaun Banega Crorepati Play Along game, where it took KBC to every home and therefore in the common man's reach.

RIL is India's largest private sector company. The company's activities span hydrocarbon exploration and production, petroleum refining and marketing, petrochemicals, retail and 4G digital services.


Related News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......